维普中文期刊产品整合服务
109篇 您的检索式:作者名="Savage DB"
    题名 作者 年代 出处 被引量
1Human metabolic sydrome resulting from dominant-negative mutation in the nuclear receptor peroxisome proliferator-activated recepter-gamma显示文摘Savage DB Tan GD Acerini CL 2003Diabetes2003,52,4:1
2Disordered lipid me-tabolism and the pathogenesis of insulin resistance显示文摘Savage DB Petersen KF Shulman GI 2007PhysiolRev2007,87,2:1
3Disordered lipid me- tabolism and the pathogenesis of insulin resistance显示文摘Savage DB Petersen KF Shulman GI 2007Physi- ol Rev2007,87,2:1
4Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome prolife rator-actived receprgamma 显示文摘Savage DB Tan GD Acerini CL 2004Diabetes2004,52,7:1
5Disorder lipid metabolismand the pathengenesis of insulin resistence 显示文摘Savage DB Petersen KF Shulman GI 2007Physiol Rev2007,87,2:1
6Resistin/Fizz 3 expression inrelation to obesity and peroxisome proliferator-activated receptor-gamma action in humans显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,10:1
7Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,10:1
8Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptorvaction in humans 显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,:1
9Resistin/Fizz3 expression in relation to obesity and peroxisome prolifetators-activated receptor action in humans显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,10:1
10Resistin/ Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,10:1
11Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-action in humans 显示文摘Savage DB Sewter Cp Klenk ES 2001Diabetes2001,50,:1
12Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2 显示文摘Savage DB Choii CS Samuel VT 2006J Clin Invest2006,116,:1
13Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans显示文摘Savage DB Sewter CP Klenk ES 2001Diabetes2001,50,:1
14PPAR gamma as a metabolic regulator:insights from genomics and pharmacology显示文摘Savage DB 2005Expert Rev Mol Med2005,7,1:1
15The metabolic syndrome : peroxisome proliferator-activated receptor γ and its therapeutic modulation 显示文摘Gurnell M Savage DB Chatterjee KK The Journal of Clinical Endocrinology & Metabolism0,88,6:1
16Disordered lipid metabolism and the pathogenesis of insulin resistance 显示文摘Savage DB Petersen KF Shulman GI 2007Physiol Rev2007,87,2:1
17Mechanisms of insulin resistance in humans and possible links with inflammation显示文摘Savage DB Petersen KF Shulman GI 2005Hypertension2005,45,5:1
18Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferators activated receptor gamma显示文摘Savage DB Tan GD Acerini CL 2003Diabetes2003,52,4:1
19The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation显示文摘Gurnell M Savage DB Chatterjee VK 2003J Clin Endocrinol Metab2003,88,6:1
20Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor PPARγ显示文摘 Tan GD Acerini CL 2003Diabetes2003,52,4:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费